Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial
- czytaj na:
kardiolog.pl
Cost and effectiveness of glycoprotein IIb/IIIa-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention
- czytaj na:
kardiolog.pl
Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study.
- czytaj na:
kardiolog.pl
Switching from abciximab to eptifibatide for percutaneous coronary interventions: a local analysis (SWAP study).
- czytaj na:
kardiolog.pl